Public Profile

ICOS Corporation

ICOS Corporation, headquartered in the United States, is a prominent player in the biotechnology industry, specialising in the development of innovative solutions for the healthcare sector. Founded in 1990, the company has achieved significant milestones, including advancements in drug discovery and development, particularly in the fields of oncology and metabolic diseases. ICOS is renowned for its core products, which include cutting-edge therapeutics and diagnostic tools that leverage proprietary technologies. These offerings are distinguished by their precision and efficacy, setting ICOS apart in a competitive market. With a strong presence in North America and Europe, ICOS Corporation has established itself as a leader in biopharmaceutical innovation, consistently recognised for its contributions to improving patient outcomes and advancing medical science.

DitchCarbon Score

How does ICOS Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

31

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

ICOS Corporation's score of 31 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

ICOS Corporation's reported carbon emissions

ICOS Corporation, headquartered in the US, currently does not have publicly available carbon emissions data for recent years. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. In the absence of detailed emissions data, it is important to note that ICOS Corporation has not outlined any specific reduction targets or commitments to climate initiatives. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability and carbon neutrality, ICOS Corporation's future commitments and actions will be crucial in aligning with global climate goals. The absence of current data highlights an opportunity for the company to enhance transparency and engage in meaningful climate action.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. ICOS Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for ICOS Corporation is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

ICOS Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Merck And Co

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Genentech

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Bms

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Novartis

CH
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Amgen

US
Chemicals nec
Updated 2 days ago

Pfizer

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers